Literature DB >> 19952710

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.

Amélie Guihot1, Roland Tubiana, Guillaume Breton, Anne-Geneviève Marcelin, Assia Samri, Lambert Assoumou, Emilia Goncalves, François Bricaire, Dominique Costagliola, Vincent Calvez, Christine Rouzioux, Brigitte Autran, Christine Katlama, Guislaine Carcelain.   

Abstract

The effects of a 10-year control of HIV replication without viral blips with antiretroviral therapy were examined in progressors. CD4 cell counts did not plateau but showed a continuous increase until the 10th year. Ultrasensitive techniques showed very low plasma HIV RNA and cell-associated DNA levels. Robust memory T cell responses to HIV-p24 were higher than in 3-year treated patients and comparable to those of Elite controllers, whereas interferon-gamma-producing HIV-specific T cells were infrequent. Long-term and efficient antiretroviral therapy provides continuous benefits both on the immune system and on the HIV reservoirs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19952710     DOI: 10.1097/QAD.0b013e32833556f3

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  22 in total

Review 1.  Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Authors:  Véronique Avettand-Fènoël; Laurent Hocqueloux; Jade Ghosn; Antoine Cheret; Pierre Frange; Adeline Melard; Jean-Paul Viard; Christine Rouzioux
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

2.  Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.

Authors:  Bret J Rudy; Bill G Kapogiannis; Carol Worrell; Kathleen Squires; James Bethel; Su Li; Craig M Wilson; Allison Agwu; Patricia Emmanuel; Georgine Price; Stephanie Hudey; Maureen M Goodenow; John W Sleasman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

Review 3.  A comparative analysis of blood pressure in HIV-infected patients versus uninfected controls residing in Sub-Saharan Africa: a narrative review.

Authors:  Edith Phalane; Carla M T Fourie; Catharina M C Mels; Aletta E Schutte
Journal:  J Hum Hypertens       Date:  2020-07-24       Impact factor: 3.012

Review 4.  Immune mechanisms of HIV control.

Authors:  Lisa A Chakrabarti; Viviana Simon
Journal:  Curr Opin Immunol       Date:  2010-08       Impact factor: 7.486

5.  Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort.

Authors:  Alan R Lifson; Elizabeth M Krantz; Lynn E Eberly; Matthew J Dolan; Vincent C Marconi; Amy C Weintrob; Nancy F Crum-Cianflone; Anuradha Ganesan; Patricia L Grambsch; Brian K Agan
Journal:  AIDS Res Ther       Date:  2011-01-18       Impact factor: 2.250

6.  HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.

Authors:  Benoît Vingert; Daniela Benati; Olivier Lambotte; Pierre de Truchis; Laurence Slama; Patricia Jeannin; Moran Galperin; Santiago Perez-Patrigeon; Faroudy Boufassa; William W Kwok; Fabrice Lemaître; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

7.  Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.

Authors:  Kaitlin Rainwater-Lovett; Hope Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn B Moore; Joseph Margolick; William J Moss
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

8.  Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.

Authors:  Ana Horta; Claudia Nobrega; Pedro Amorim-Machado; Vitor Coutinho-Teixeira; Palmira Barreira-Silva; Susana Boavida; Patrício Costa; Rui Sarmento-Castro; António Gil Castro; Margarida Correia-Neves
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors.

Authors:  Cristina Cellerai; Alexandre Harari; Hans Stauss; Sabine Yerly; Anna-Maria Geretti; Anne Carroll; Thynn Yee; Jonathan Ainsworth; Ian Williams; John Sweeney; Andrew Freedman; Margaret Johnson; Giuseppe Pantaleo; Sabine Kinloch-de Loes
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

10.  Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency.

Authors:  Denise C Hsu; Stephen J Kerr; Thatri Iampornsin; Sarah L Pett; Anchalee Avihingsanon; Parawee Thongpaeng; John J Zaunders; Sasiwimol Ubolyam; Jintanat Ananworanich; Anthony D Kelleher; David A Cooper
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.